1-44827617-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_003738.5(PTCH2):c.2156G>A(p.Arg719Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000143 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R719W) has been classified as Likely benign.
Frequency
Consequence
NM_003738.5 missense
Scores
Clinical Significance
Conservation
Publications
- nevoid basal cell carcinoma syndromeInheritance: AD, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- commissural facial cleftInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PTCH2 | ENST00000372192.4 | c.2156G>A | p.Arg719Gln | missense_variant | Exon 15 of 22 | 1 | NM_003738.5 | ENSP00000361266.3 | ||
| PTCH2 | ENST00000447098.7 | c.2156G>A | p.Arg719Gln | missense_variant | Exon 15 of 23 | 1 | ENSP00000389703.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000280 AC: 7AN: 250256 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461526Hom.: 0 Cov.: 37 AF XY: 0.0000165 AC XY: 12AN XY: 727054 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74354 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Gorlin syndrome Uncertain:2
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PTCH2 protein function. ClinVar contains an entry for this variant (Variation ID: 6147). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This missense change has been observed in individual(s) with nevoid basal cell carcinoma syndrome (NBCCS) (PMID: 18285427). This variant is present in population databases (rs121434397, gnomAD 0.008%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 719 of the PTCH2 protein (p.Arg719Gln). -
- -
Basal cell nevus syndrome 1 Uncertain:1
The PTCH2 c.2156G>A (p.Arg719Gln) missense change has a maximum subpopulation frequency of 0.008% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org). The in silico tool REVEL predicts a deleterious effect on protein function. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at